0001567619-21-008381.txt : 20210420 0001567619-21-008381.hdr.sgml : 20210420 20210420215318 ACCESSION NUMBER: 0001567619-21-008381 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210419 FILED AS OF DATE: 20210420 DATE AS OF CHANGE: 20210420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davis George Eric CENTRAL INDEX KEY: 0001380710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 21839455 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2021-04-19 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001380710 Davis George Eric C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 0 1 0 0 EVP, General Counsel Common Stock 2021-04-19 4 M 0 2709 26.49 A 71149 D Common Stock 2021-04-19 4 S 0 2709 79.58 D 68440 D Stock Option (Right to buy Common Stock) 26.49 2021-04-19 4 M 0 2709 0 D 2011-11-12 2021-05-11 Common Stock 2709 0 D Trade made pursuant to a 10b5-1 plan executed on March 12, 2021. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Eric Fleekop, Attorney-in-Fact 2021-04-20